Dr. Saoirse Elizabeth O’Sullivan
Professor Saoirse Elizabeth O’Sullivan (@ScienceSaoirse) received her doctorate from Trinity College Dublin in 2001 and moved to the University of Nottingham in 2002 as a Research fellow where she began researching cannabinoid pharmacology through basic and clinical research. She was made Lecturer in 2007, Associate Professor in 2011 and Full Professor in 2019. She has over 40 peer-reviewed articles and 3 books chapters on the topic of cannabinoid pharmacology. Her specific interests are on the therapeutic potential of cannabis-based medicines and modulating the endocannabinoid system in cardiovascular disease, stroke, diabetes, and inflammatory bowel disease. In 2016 she was named the International Cannabinoid Research Society Young Investigator of the Year. Saoirse runs an independent consulting company called CanPharmaConsulting Ltd, and through this, acts as scientific advisor to Artelo Biosciences, CBDScience Group and Dragonfly Biosciences. She is the science lead for the newly formed Centre for Medicine Cannabis (CMC), a non-profit organisation working to shape the UK’s new medicinal cannabis regime in the interests of patient. She also works with many charities, patient groups and healthcare professionals to educate on the benefits of cannabis-based medicines.